Jose Asumendi analyst JPMORGAN

Currently out of the existing stock ratings of Jose Asumendi, 4 are a HOLD (50%), 4 are a BUY (50%).

Jose Asumendi

Work Performance Price Targets & Ratings Chart

Analyst Jose Asumendi, currently employed at JPMORGAN, carries an average stock price target met ratio of 77.08% that have a potential upside of 32.59% achieved within 341 days.

Jose Asumendi’s has documented 18 price targets and ratings displayed on 6 stocks. The coverage is on Consumer Cyclical, Financial Services sectors.

Most recent stock forecast was given on STLA, Stellantis NV at 24-Feb-2022.

Wall Street Analyst Jose Asumendi

Analyst best performing recommendations are on VNE (VEONEER).
The best stock recommendation documented was for VNE (VEONEER) at 4/16/2021. The price target of $24 was fulfilled within 4 days with a profit of $1.78 (6.9%) receiving and performance score of 17.26.

Average potential price target upside

AG First Majestic Silver Corp QS Quantumscape Corp AB AllianceBernstein Holding L.P. VNE Veoneer STLA Stellantis NV FREY FREYR Battery SA

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$6.5

$0.06 (0.93%)

$5.5

6 months 1 days ago
(23-May-2024)

2/2 (100%)

$-0.54 (-7.67%)

34

Hold

$4.18

$-2.26 (-35.09%)

$4.8

10 months 20 days ago
(04-Jan-2024)

3/6 (50%)

$-1.43 (-25.49%)

50

Hold

$13.2

1 years 18 days ago
(06-Nov-2023)

2/2 (100%)

$0.01 (0.08%)

80

Hold

1 years 10 months 5 days ago
(20-Jan-2023)

1/1 (100%)

$2.12 (21.46%)

71

Buy

$12

$2.38 (24.74%)

$12

2 years 1 months 6 days ago
(19-Oct-2022)

1/9 (11.11%)

$8.22 (79.77%)

106

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jose Asumendi?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?